Xenon Pharmaceuticals (XENE) Revenue (2013 - 2025)

Xenon Pharmaceuticals (XENE) has 10 years of Revenue data on file, last reported at $7.5 million in Q1 2025.

• On a quarterly basis, Revenue changed N/A year-over-year to $7.5 million in Q1 2025; TTM through Dec 2025 was $7.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at $7.5 million, changed N/A from the prior year.
• Revenue for Q1 2025 stood at $7.5 million, up from $132000.0 in the prior quarter.
• Over the last five years, Revenue for XENE reached as high as $8.8 million in Q1 2022 and fell as low as $132000.0 in Q3 2022.
• Historically, Revenue has averaged $4.4 million across 3 years, with a median of $4.0 million in 2021.
• On a YoY basis, Revenue climbed as much as 101.15% in 2022 and fell as far as 98.38% in 2022.
• Year by year, Revenue stood at $3.7 million in 2021, then tumbled by 96.47% to $132000.0 in 2022, then surged by 5581.82% to $7.5 million in 2025.
• Per Business Quant data, the three most recent Revenue figures were $7.5 million in Q1 2025, $132000.0 in Q3 2022, and $536000.0 in Q2 2022.